Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH1243598427
Tue, 09.09.2025       Sandoz Group AG

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Agreement clears path for launch of Enzeevu™ (aflibercept-abzv) by end of 2026  Enzeevu™ is an FDA-approved Sandoz biosimilar to Eylea® Anticipated launch further strengthens Sandoz biosimilar portfolio, advances growth strategy in US and ensures more patients have access to [ … ]
Thu, 28.08.2025       Sandoz Group AG

Sandoz Group AG / Key word(s): Product Launch Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options 28.08.2025 / 07:00 CET/CEST Media Release With introduction of 10 mg, 15 mg and 20 mg strengths, Sandoz now provides most comprehensive range of rivaroxaban film-coated tablets [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2025 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2025 WEBs Investments ETFs
Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Saturday, 13.09.2025, Calendar Week 37, 256th day of the year, 109 days remaining until EoY.